These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 830759)

  • 1. Immunization with p30 enhances the growth of a rat Moloney sarcoma.
    Jones JM; Kennel SJ; Feldman JD
    J Immunol; 1977 Jan; 118(1):371-3. PubMed ID: 830759
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
    Gorczynski RM; Knight RA
    Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated antigens of rat moloney sarcoma cells. II. Cytosol antigens.
    Leung K; Feldman JD
    J Immunol; 1978 Nov; 121(5):1844-8. PubMed ID: 309482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serochemotherapy against a Moloney virus-induced leukemia.
    Pearson GR; Redmon LW; Pearson JW
    Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 6. p30-Anti-p30 immune complexes: intravascular clearance and extravascular sequestration in rats bearing Moloney sarcoma.
    Jennette JC; Feldman JD
    J Immunol; 1978 Nov; 121(5):1696-700. PubMed ID: 712062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and pathological manifestations of murine sarcoma virus (Moloney) infections.
    Schlom J; Moloney JB; GroupƩ V
    Cancer Res; 1970 Dec; 30(12):2955-61. PubMed ID: 5494580
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Fefer A
    Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB; Knight RA
    Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effects of xenogeneic antiserum on the growth of Moloney virus-induced sarcomas.
    Pierce GE
    J Surg Oncol; 1977; 9(3):249-56. PubMed ID: 875394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody and antigen levels in rats inoculated with Moloney sarcomas and viral antigens.
    Soderberg F; Jones JM
    Eur J Cancer (1965); 1980 Feb; 16(2):285-8. PubMed ID: 7371683
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of macrophages and antibodies on in vivo growth of Moloney sarcoma in the rat.
    Miller GA; Feldman JD
    J Immunol; 1977 Oct; 119(4):1445-51. PubMed ID: 302284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas.
    Jennette JC; Feldman JD
    J Immunol; 1977 Jun; 118(6):2269-74. PubMed ID: 301157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to Moloney type C virus-induced tumours.
    Hogg N; Wallace D; Smart JE
    Nature; 1980 Jan; 283(5744):304-6. PubMed ID: 6243399
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
    Lavrin DH; Herberman RB; Nunn M; Soares N
    J Natl Cancer Inst; 1973 Nov; 51(5):1497-508. PubMed ID: 4762933
    [No Abstract]   [Full Text] [Related]  

  • 18. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse.
    PazmiƱo NH; Yuhas JM
    Cancer Res; 1973 Nov; 33(11):2668-72. PubMed ID: 4748428
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic control of immune responses to Moloney leukemia virus in rats.
    Jones JM; Jensen F; Feldman JD
    J Natl Cancer Inst; 1978 Jun; 60(6):1467-72. PubMed ID: 206712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus.
    Jones JM; Jensen F; Veit B; Feldman JD
    J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.